 |
PDBsum entry 4ehz
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4ehz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
The jak1 kinase domain in complex with inhibitor
|
|
Structure:
|
 |
Tyrosine-protein kinase jak1. Chain: a, b, c, d. Fragment: kinase domain, unp residues 854-1154. Synonym: janus kinase 1, jak-1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: jak1, jak1a, jak1b. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
|
|
Resolution:
|
 |
|
2.17Å
|
R-factor:
|
0.174
|
R-free:
|
0.229
|
|
|
Authors:
|
 |
P.J.Lupardus,M.Steffek
|
|
Key ref:
|
 |
M.Zak
et al.
(2012).
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.
J Med Chem,
55,
6176-6193.
PubMed id:
|
 |
|
Date:
|
 |
|
04-Apr-12
|
Release date:
|
04-Jul-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P23458
(JAK1_HUMAN) -
Tyrosine-protein kinase JAK1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1154 a.a.
292 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
J Med Chem
55:6176-6193
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.
|
|
M.Zak,
R.Mendonca,
M.Balazs,
K.Barrett,
P.Bergeron,
W.S.Blair,
C.Chang,
G.Deshmukh,
J.Devoss,
P.S.Dragovich,
C.Eigenbrot,
N.Ghilardi,
P.Gibbons,
S.Gradl,
C.Hamman,
E.J.Hanan,
E.Harstad,
P.R.Hewitt,
C.A.Hurley,
T.Jin,
A.Johnson,
T.Johnson,
J.R.Kenny,
M.F.Koehler,
P.Bir Kohli,
J.J.Kulagowski,
S.Labadie,
J.Liao,
M.Liimatta,
Z.Lin,
P.J.Lupardus,
R.J.Maxey,
J.M.Murray,
R.Pulk,
M.Rodriguez,
S.Savage,
S.Shia,
M.Steffek,
S.Ubhayakar,
M.Ultsch,
A.van Abbema,
S.I.Ward,
L.Xiao,
Y.Xiao.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |